"Concerns About Patient Safety and Access to Essential Medication"

I am writing to share my experience with the practice and to raise concerns about patient safety, prescribing governance, and the handling of urgent clinical matters. I am submitting this to CareOpinion because I believe it is important for patient voices to be heard, and for patterns of concern to be visible so that services can reflect, learn, and improve. My intention is not to criticise individual staff members, but to highlight what appear to be systemic issues that may be placing patients at risk, particularly those who rely on essential long‑term medication and monitoring.

A recent incident prompted me to reflect more deeply on the processes in place. On this occasion, my access to a life‑sustaining medication was unexpectedly interrupted due to an internal prescribing review. I had informed the practice that I had completely run out of the medication and that my next dose was due that same evening. Despite the clear urgency and the potential for significant harm if treatment was delayed, the situation was not initially treated with the seriousness one would reasonably expect. The prescription was only issued after I reiterated the immediate risk and emphasised the clinical consequences of missing doses.

This experience was deeply concerning. When a patient relies on essential medication to maintain their health and prevent deterioration, continuity of treatment should be protected by robust safeguards. Administrative processes, internal reviews, or workflow delays should never interrupt access to medication that is critical for ongoing stability. In this instance, there appeared to be no urgent triage, no safety‑netting, and no proactive escalation, even though the risk of harm was clear and explicitly communicated. It left me questioning whether the practice has adequate systems in place to identify and prioritise situations where medication continuity is vital.

What troubles me further is that this incident does not seem to be an isolated event. Over time, I have experienced several issues relating to communication, delays, and decision‑making around essential diabetes management, including access to monitoring equipment and supplies. These are not minor inconveniences; they are fundamental components of safe and effective long‑term condition management. When delays or miscommunications occur repeatedly, it raises questions about whether the underlying governance processes are sufficiently robust to ensure patient safety.

For example, there have been occasions where requests for essential equipment or medication have been delayed without explanation, or where communication has been unclear or inconsistent. At times, I have found it difficult to obtain straightforward responses when raising concerns or seeking clarification. This can leave patients feeling uncertain, anxious, and unsure whether similar issues might occur again.

In a healthcare setting, especially one responsible for managing long‑term conditions, patients should feel confident that their concerns will be taken seriously and that systems are designed to prevent avoidable harm. When communication is inconsistent or when urgent matters are not triaged appropriately, it undermines trust and creates a sense of vulnerability. Patients should not have to repeatedly advocate for themselves to ensure that essential medication is issued on time or that urgent risks are recognised.

My intention in sharing this with CareOpinion is not simply to highlight a single incident, but to draw attention to what appears to be a broader pattern relating to processes, communication, and safety culture. CareOpinion plays an important role in giving patients a platform to describe their experiences, and I hope that by sharing mine, the practice will have the opportunity to reflect on whether its systems are consistently protecting patients who rely on essential medication and monitoring.

I believe it would be helpful for the practice to consider reviewing its internal processes to ensure that safeguards are in place for essential medications, including:

- Clear protocols to prevent interruptions in treatment during internal reviews  

- Effective triage systems to identify and prioritise urgent medication‑related risks  

- Safety‑netting processes to ensure that patients are not left without essential treatment  

- Transparent communication pathways so patients understand what is happening and why  

These are fundamental components of safe clinical practice, and they are especially important for patients with long‑term conditions who depend on consistent access to medication and monitoring.

I also believe there may be opportunities for the practice to strengthen its communication processes. When patients raise legitimate concerns about safety, they should receive timely, clear, and reassuring responses. Accountability should be visible, and patients should feel confident that their concerns have been heard, understood, and acted upon. At present, this does not always seem to be the case.

A strong safety culture is one in which concerns are welcomed, not dismissed; where systems are designed to prevent harm rather than react to it; and where communication is open, transparent, and proactive. My experiences suggest that there may be room for improvement in these areas. I hope that by raising these concerns constructively through CareOpinion, the practice will have the opportunity to reflect on its processes and consider whether changes are needed to better protect patients.

Continuity of care is not simply a matter of convenience—it is a cornerstone of patient safety. When essential medication is involved, even a short interruption can have serious consequences. Patients should never be placed in a position where they must repeatedly chase prescriptions, explain the urgency of their situation, or worry about whether their next dose will be available on time. These are preventable risks, and they should be addressed through strong governance and reliable systems.

I appreciate that primary care services are under immense pressure and that staff are working hard in challenging circumstances. My intention is not to overlook these realities, but to highlight that even under pressure, certain safeguards must remain non‑negotiable. Essential medication continuity is one of them.

I hope that by sharing my experience through CareOpinion, the practice will take the opportunity to review the systems currently in place and ensure that they are sufficiently robust to protect patients who rely on long‑term treatment.